OCTOBIDPublic Tender Gazetteoctobid.net
Avant Garde/Avenir Awards for Investigators Conducting High Risk/High Reward Research on HIV and Substance Use (or Substance Use Disorders) (DP1 Clinical Trial Optional)
synopsis monitored from grants-gov.
- Buyer / agency
- National Institutes of Health
- Notice type
- synopsis
- Solicitation number
- PAR-27-026
- Posted
- June 9, 2026
- Response deadline
- September 25, 2028
- Location
- US
- Estimated value
- Not published by the source
- NAICS
- Not supplied
- Source
- grants-gov
Summary
The purpose of this notice of funding opportunity (NOFO) is to support innovative basic, clinical, translational, and implementation science research relevant to HIV and substance use. This initiative encourages high risk high impact transformative studies that advance knowledge and strategies for HIV prevention, diagnosis, treatment and virus suppression in people who use substances and/or have a substance use disorder.
See the official source link, all documents, and the full solicitation text — and prepare a proposal working draft with AI — with a free Octobid account.
Summaries are indexed from official public sources; the issuing platform’s notice, documents, and amendments always control.